PHARPharming Group N.V.
$9.70-34% 1Y
$9.70
$9.7052 weeks$21.18
What is the market doing?
Watch
1 to watch, 2 without dataIn a downtrend (−34% vs 200-day). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendDowntrendderived · Oct 6, 2026
In a downtrend, below its 50- and 200-day averages. Price is −34% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PHAR is trading
Pharming Group N.V. is −34% over the past year while the S&P 500 is +18%: 53 points behind the market.
−34%
1-year return · S&P 500 +18%
- vs 200-day average
- −34%
vs 200-day average · a clear downtrend
- RSI (14)
- 37
RSI (14) · neutral
- Below its 52-week high
- 54%
Below its 52-week high
Details›
- Last close2026-10-06
- $9.70
- 1 monthS&P 500 +1.6%
- −14%
- 1 yearS&P 500 +18%
- −34%
- 5 yearsS&P 500 +86%
- −12%
- vs 50-day average$11.22
- −14%
- 52-week high
- $21.18
- 52-week low
- $9.70
- Annualised volatility
- 66%
| Year | Return |
|---|---|
| 2026 (year to date) | −45% |
| 2025 | +76% |
| 2024 | −12% |
| 2023 | +3.6% |
| 2022 | +23% |
| 2021 | −41% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 6 | 4 of 6 | +5.0% |
| Feb | 6 | 1 of 6 | −6.9% |
| Mar | 6 | 2 of 6 | −0.86% |
| Apr | 6 | 2 of 6 | −5.1% |
| May | 6 | 2 of 6 | −1.1% |
| Jun | 6 | 3 of 6 | −0.90% |
| Jul | 6 | 3 of 6 | −5.6% |
| Aug | 6 | 4 of 6 | +17% |
| Sep | 6 | 1 of 6 | −8.3% |
| Oct | 6 | 2 of 6 | −1.4% |
| Nov | 5 | 2 of 5 | +6.3% |
| Dec | 5 | 3 of 5 | +7.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.